The first week of November marked the European Fertility week 2020, calling for European policymakers to ensure equal, fair and safe access to fertility treatments.
The new resources from the ReproUnion Biobank & Infertility Cohort (RUBIC) will enhance the dialogue with couples interested in the research project.
In his final State of the Union Address in 2016, President Obama called on then Vice President Biden to lead a new, national “Moonshot” initiative to eliminate cancer as we know it. The European Cancer Moonshot Lund Center was established and ReproUnion board member, Professor Johan Malm, had the pleasure to meet Joe Biden.
“We need deeper insights about the biology associated with ovarian ageing to provide future strategies for prevention and/or treatments of age-related female infertility. Ultimately, a clinical biomarker for ovarian ageing would enable women to better plan the time for pregnancy – according to their own life preferences in combination with their own biology,” said Kristina Wendelboe Olsen, who defended her PhD on th25 September 2020.
ReproUnion’s challenge 3 is building detailed knowledge of ovarian function towards the ultimate aim of creating a human artificial ovary within a ten-year period. This includes methods to mature oocytes outside the body (IVM), which is contributing to set the agenda worldwide
460 women from Denmark, Sweden and Spain participated in the study, which shows similar ongoing pregnancy rates after frozen compared to fresh embryo transfer.
ESHRE’s first virtual conference showcases ReproUnion-supported research and fertility counselling service
On the 5th of July, the European Society of Human Reproduction and Embryology (ESHRE) kicked off its 36th Annual Meeting as a virtual conference with 12,191 participants from all over the world.
Eva Hoffmann is one of the 63 leading scientists from 25 countries, who have been bestowed the lifetime honour of EMBO Membership in recognition of their remarkable research achievements.
On the 6th of May, Fertility & Sterility under the American Society of Reproductive Medicine published the study, which used data from the Fetal Programming of Semen Quality (FEPOS) cohort, co-funded by ReproUnion.
Fostering the next generation of researchers is vital to meet the future demands of managing and preventing infertility problems. In 2015-18 ReproUnion supported 24 research projects.